79397582 - ACTINEER

Information

• Trademark
• 79397582

• Source

• Serial Number

  79397582

• Registration Number

  7741628

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 08, 2024
  a year ago

• Registration Date

  April 01, 2025
  7 months ago

• Transaction Date

  July 03, 2025
  4 months ago

• Status Date

  April 01, 2025
  7 months ago

• Published for Opposition Date

  February 11, 2025
  8 months ago

• Location Date

  March 31, 2025
  7 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  FRENCH, CURTIS

• Attorney Docket Number

  540.326US

  Attorney Name

  Kari Moyer-Henry

• Owners

  • ITM Isotope Technologies Munich SE

Case File Statements

• DM0000: The mark consists of the term ACTINEER is stylized font with a design of a stylized ribbon to the left of the wording.
• GS0051: Radiopharmaceutical diagnostic preparations for medical purposes; radiopharmaceutical diagnostic preparations for pharmaceutical purposes; radiopharmaceutical therapeutic preparations for medical purposes; radiopharmaceutical therapeutic preparations for pharmaceutical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy, positron emission tomography, single photon emission computed tomography, target radionuclide therapy and peptide receptor radionuclide therapy; radiopharmaceutical preparations, in particular actinium-containing radiopharmaceutical products in GMP quality; radiopharmaceutical preparations, in particular bismuth-containing radiopharmaceutical products in GMP quality; radiopharmaceutical preparations for use in oncology, in particular radiopharmaceuticals containing radioisotopes, in particular actinium-225; radiopharmaceutical preparations for use in oncology, in particular radiopharmaceuticals containing radioisotopes, in particular bismuth-213; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular actinium-225 for the treatment of tumour diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular bismuth-213 for the treatment of tumour diseases; target radiopharmaceuticals containing a target molecule, in particular peptide , depending on the indication, and a medical radioactive isotope; target radiopharmaceuticals containing a target molecule, in particular an antibody depending, on the indication, and a medical radioactive isotope; radiopharmaceuticals containing actinium-225 and its complexes; radiopharmaceuticals containing bismuth-213 and its complexes
• GS0011: Chemical substances, chemical materials and chemical preparations for use in the manufacture of medical products; chemical substances, chemical materials and chemical preparations for use in the manufacture of radiopharmaceutical products; chemical raw materials, in particular actinium-225 radiochemical, for the formulation of radiopharmaceutical products; chemical raw materials, in particular bismuth-213, for the formulation of radiopharmaceutical products
• GS0441: Medical services, in particular medical services relating to radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology, nuclear medicine and brachytherapies, namely intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and radionuclide therapy, peptide receptor radionuclide therapy, personal nuclear medicine and precision oncology; medical services for theranostics in the field of precision oncology
• GS0101: Medical instruments, apparatus and containers for the production of radiopharmaceutical preparations, namely sample preparation devices automatically or manually operated in particular for the production of actinium-225 in GMP quality; medical instruments, apparatus and containers for the production of radiopharmaceutical preparations, namely sample preparation devices automatically or manually operated in particular for the production of bismuth-213 in GMP quality; control, regulation and measuring apparatus as parts of medical instruments, apparatus and containers, in particular devices containing fluidic processing components as valves, small vessels (5-500 ml) and purification columns for the production of a radiotherapeutic or radiodiagnostic substance, in particular for the production of actinium-225 in GMP quality; control, regulation and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular devices containing fluidic processing components as valves, small vessels (5-500 ml) and purification columns for the production of a radiotherapeutic or radiodiagnostic substance, in particular for the production of bismuth-213 in GMP quality; radionuclide generator for radiopharmaceutical purpose
• GS0421: Scientific and technological services and research relating to the use of actinium-225, in particular medical and pharmacological research services relating to the use of actinium-225; scientific and technological services and research relating to the use of bismuth-213, in particular medical and pharmacological research services relating to the use of bismuth-213; scientific and technological services and research relating to the use of other alpha emitters, in particular medical and pharmacological research services relating to the use of other alpha emitters

Case File Event Statements

• 6/13/2024 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 9/2/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/20/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/20/2024 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/8/2024 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/9/2024 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/11/2024 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 9/11/2024 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/18/2024 - 10 months ago

  14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/18/2024 - 10 months ago

  12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/30/2024 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/18/2024 - 10 months ago

  11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/30/2024 - 10 months ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/18/2024 - 10 months ago

  10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/18/2024 - 10 months ago

  13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/30/2024 - 10 months ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/30/2024 - 10 months ago

  15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/21/2025 - 9 months ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/5/2025 - 8 months ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/11/2025 - 8 months ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/11/2025 - 8 months ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/1/2025 - 7 months ago

  23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/2/2025 - 4 months ago

  24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 4/1/2025 - 7 months ago

  22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR